COMMUNIQUÉS West-GlobeNewswire

Exergen Corporation Senior Vice President Joins Northeastern University School of Nursing Faculty

27/02/2018 - 13:00

WATERTOWN, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Exergen Corporation is pleased to announce that its Senior Vice President and Chief Clinical Scientist, Dr. Marybeth Pompei, has accepted a new Affiliate Professor [...]

Optinose to Highlight Data at the 2018 AAAAI/WAO Joint Congress

27/02/2018 - 13:00

YARDLEY, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will [...]

Evogene Announces Positive Results in its Novel Mode-of-Action Herbicide Program

27/02/2018 - 13:00

REHOVOT, Israel, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN )) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique [...]

Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine

27/02/2018 - 13:00

HAIFA, Israel, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI ) (TASE: PSTI ), a leading developer of placenta-based cell therapy products, announced today that Frontiers in Medicine has [...]

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis

27/02/2018 - 13:00

LONDON and CARLSBAD, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]

Transactions in relation to share buyback program

27/02/2018 - 12:39

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Epizyme Announces Date of Fourth Quarter and Full Year 2017 Results Conference Call and Upcoming Presentation at the Cowen 38th Annual Health Care Conference

27/02/2018 - 12:30

CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will host a conference [...]

Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results

27/02/2018 - 12:30

OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]

PotNetwork Holding Inc. Exceeds 1 Million in Sales for First 15 Days of February

27/02/2018 - 12:00

FT LAUDERDALE, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holding, Inc. (OTC Pink:POTN ) (“Company”) announced today that its wholly owned subsidiary, Diamond CBD, Inc., has reported that the [...]

Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results

27/02/2018 - 12:00

PLAINSBORO, N.J., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ) today reported financial results for the fourth quarter and full-year ended December 31, 2017. Highlights: [...]

Green Cures & Botanical Distribution, Inc. Partners with Humboldt Cannabis AF to Produce Licensed Cannabis and CBD Products

27/02/2018 - 11:30

LOS ANGELES, CA , Feb. 27, 2018 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution, Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, has signed a [...]

Amarin Reports Record Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Operations

27/02/2018 - 11:00

Record Revenue of $181.1 Million and $ 53.9 Million for Full Year and Fourth Quarter 2017 REDUCE-IT Cardiovascular Outcomes Study Remains on Schedule to Report Top-Line Results Before the End of Q3 2018 Management to [...]

Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017

27/02/2018 - 08:00

LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

OSE Immunotherapeutics Granted Approval to Resume Patient Accrual in U. S. for Phase 3 Tedopi® Clinical Trial in Advanced Non-Small Cell Lung Cancer Patients Following Immune Checkpoint Inhibitor Treatment

27/02/2018 - 07:30

NANTES, France, Feb. 27, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that the first approvals to resume patient accrual in the global Tedopi ® Phase 3 trial have been [...]

Photocure ASA: Results for the fourth quarter of 2017

27/02/2018 - 07:16

Oslo, Norway, 27 February 2018: Photocure ASA (OSE: PHO ), today reported a revenue growth of 27% for the important U.S. market in the fourth quarter of 2017, contributing to Hexvix ® /Cysview ® revenues of NOK 39.4 [...]

Basilea reports significantly improved financial results in 2017

27/02/2018 - 07:16

54% increase in total revenue, amounting to CHF 101.5 million Operating loss reduced by 68% to CHF 14.1 million Cash position as of year-end 2017 increased to CHF 310.7 million License and distribution agreements in [...]

Vistin Pharma ASA : Fourth quarter 2017 results

27/02/2018 - 07:01

Oslo, Norway, 27 February 2018 Vistin Pharma had a revenue of NOK 41.6 million in the fourth quarter 2017, compared to NOK 32.5 million in the fourth quarter 2016. Adjusted EBITDA from continuing operations came to [...]

Targovax to present at Biologics World Nordic 2018

27/02/2018 - 07:01

Oslo, Norway, 27 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the Company will present at the following [...]

Biocartis Group NV: Disclosure of a transparency notification

27/02/2018 - 07:01

PRESS RELEASE : REGULATED INFORMATION 27 February 2018, 07:00 CET Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Mechelen, [...]